SMECTA

This brand name is authorized in Ecuador, Estonia, France, Hong Kong, Lithuania, Poland, Romania, Singapore, Tunisia

Active ingredients

The drug SMECTA contains one active pharmaceutical ingredient (API):

1 Diosmectite UNII A585MN1H2L - MONTMORILLONITE

Diosmectite is a natural aluminomagnesium silicate clay with a lamellar, non-fibrous crystalline structure that gives it strong adsorbent properties. Diosmectite has demonstrated efficacy in the treatment of acute watery diarrhoea in children. Read about Diosmectite

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A07BC05	Diosmectite	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07B Intestinal adsorbents → A07BC Other intestinal adsorbents
Discover more medicines within A07BC05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 3021-MEE-0917
Country: EE	Ravimiamet	Identifier(s): 1028472, 1063640
Country: FR	Base de données publique des médicaments	Identifier(s): 64450063, 69584073
Country: HK	Department of Health Drug Office	Identifier(s): 34268
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1010356, 1010357, 1063704, 1063705, 1092607
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100016564, 100061530, 100266321, 100268662, 100334620, 100343027, 100358945, 100426836, 100455849
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66204002, W66204003
Country: SG	Health Sciences Authority	Identifier(s): 06338P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5720011